Antineo is a contract research organization providing services to academic researchers as well as private companies in preclinical therapeutic research in oncology. Our services aim to improve the use of approved anticancer agents as well as to develop novel agents, in particular thanks to the use of optimal preclinical models, expertise regarding future clinical indications, and comparisons/combinations with the most relevant compounds.
Located in the Rockefeller Medical School in Lyon and working in close partnership with the Cancer Research Center of Lyon and the Lyon hospitals, Antineo offers an exceptional environment for translational research in onco-pharmacology.
Proof of concept of antitumor activity of novel agents.
CUSTOM MODEL DEVELOPMENT
Antineo offers and develops a variety of well characterized models which are representative of solid tumors and hematological malignancies, including models which are resistant to reference compounds.
IN VIVO TOXICITY
We perform non regulatory preclinical toxicity studies.
We will provide you with rodent samples for the pharmacokinetic studies of your compounds of interest.